LLY

724.73

+1.52%↑

JNJ

179.64

+1.09%↑

ABBV

220.72

+1.15%↑

UNH

344.16

-0.42%↓

NVO

55.6

-0.82%↓

LLY

724.73

+1.52%↑

JNJ

179.64

+1.09%↑

ABBV

220.72

+1.15%↑

UNH

344.16

-0.42%↓

NVO

55.6

-0.82%↓

LLY

724.73

+1.52%↑

JNJ

179.64

+1.09%↑

ABBV

220.72

+1.15%↑

UNH

344.16

-0.42%↓

NVO

55.6

-0.82%↓

LLY

724.73

+1.52%↑

JNJ

179.64

+1.09%↑

ABBV

220.72

+1.15%↑

UNH

344.16

-0.42%↓

NVO

55.6

-0.82%↓

LLY

724.73

+1.52%↑

JNJ

179.64

+1.09%↑

ABBV

220.72

+1.15%↑

UNH

344.16

-0.42%↓

NVO

55.6

-0.82%↓

Начало・Списък с акции・Stryker Corp

Stryker Corp

Затворен

СекторЗдравеопазване

368.63 0.07

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

368

Максимум

371.01

Ключови измерители
By Trading Economics
Приходи	230M 884M
Продажби	156M 6B
P/E Средно за сектора	50.029 35.69
EPS	3.13
Дивидентна доходност	0.88
Марж на печалбата	14.68
Служители	53,000
EBITDA	634M 1.5B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+18.15% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.88% 3.08%
Следващи печалби	28.10.2025 г.
Следваща дата на дивидент	31.10.2025 г.
Следваща дата на екс-дивидент	30.09.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-8.5B 145B
Предишно отваряне	368.56
Предишно затваряне	368.63

Настроения в новините

By Acuity

35%

65%

94 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Weak Bullish Evidence

373.92 / 383.99 Подкрепа & съпротива

Stryker Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

31.07.2025 г., 20:42 ч. UTC

Печалби

Stryker Lifts Guidance on Improving Tariff Outlook

1.05.2025 г., 20:56 ч. UTC

Печалби

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

28.01.2025 г., 21:55 ч. UTC

Печалби

Stryker Sees Further Organic Sales Growth in 2025

28.01.2025 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

31.07.2025 г., 20:09 ч. UTC

Печалби

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31.07.2025 г., 20:09 ч. UTC

Печалби

Stryker Sales >SYK

31.07.2025 г., 20:09 ч. UTC

Печалби

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31.07.2025 г., 20:05 ч. UTC

Печалби

Stryker 2Q Sales $6B >SYK

31.07.2025 г., 20:05 ч. UTC

Печалби

Stryker 2Q Net $884M >SYK

31.07.2025 г., 20:05 ч. UTC

Печалби

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31.07.2025 г., 20:05 ч. UTC

Печалби

Stryker 2Q EPS $2.29 >SYK

31.07.2025 г., 20:05 ч. UTC

Печалби

Stryker 2Q Adj EPS $3.13 >SYK

31.07.2025 г., 20:05 ч. UTC

Печалби

Stryker 2Q Sales $6B >SYK

31.07.2025 г., 20:05 ч. UTC

Печалби

Stryker 2Q EPS $2.29 >SYK

31.07.2025 г., 20:05 ч. UTC

Печалби

Stryker 2Q EPS $2.29 >SYK

1.05.2025 г., 20:41 ч. UTC

Печалби

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1.05.2025 г., 20:11 ч. UTC

Печалби

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1.05.2025 г., 20:10 ч. UTC

Печалби

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1.05.2025 г., 20:05 ч. UTC

Печалби

Stryker 1Q Adj EPS $2.84 >SYK

1.05.2025 г., 20:05 ч. UTC

Печалби

Stryker 1Q Net $654M >SYK

1.05.2025 г., 20:05 ч. UTC

Печалби

Stryker 1Q EPS $1.69 >SYK

1.05.2025 г., 20:05 ч. UTC

Печалби

Stryker 1Q Sales $5.87B >SYK

1.05.2025 г., 20:05 ч. UTC

Печалби

Stryker 1Q EPS $1.69 >SYK

19.02.2025 г., 13:53 ч. UTC

Придобивния, сливания и поглъщания

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19.02.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28.01.2025 г., 21:09 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28.01.2025 г., 21:09 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28.01.2025 г., 21:08 ч. UTC

Придобивния, сливания и поглъщания

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28.01.2025 г., 21:08 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28.01.2025 г., 21:06 ч. UTC

Печалби

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

Сравнение с други в отрасъла

Ценова промяна

Stryker Corp Прогноза

Ценова цел

By TipRanks

18.15% нагоре

12-месечна прогноза

Среден 436 USD 18.15%

Висок 456 USD

Нисък 407 USD

Според 18 анализатори от Wall Street, предложили 12-месечна ценова цел за Stryker Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

18 ratings

Купи

Задържане

Продай

Според 18 анализатори, дали борсови рейтинги на Stryker Corp през последните 3 месеца.

Техническа оценка

By Trading Central

373.92 / 383.99Подкрепа & съпротива

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Настроение

By Acuity

94 / 371 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.